| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 06/01/2004 | US6743927 Process for enantioselectively producing the (r)-delta-lactone |
| 06/01/2004 | US6743888 Having protected pendant hydroxyl group capable of cross-linking with polyisocyanate; robust durable photoconductive imaging members; solvent and abrasion resistance |
| 05/27/2004 | WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | WO2004043884A2 Novel acylating reagents |
| 05/27/2004 | WO2003089396A8 Direct, enantioselective aldol coupling of aldehydes using chiral organic catalysts |
| 05/27/2004 | US20040102516 Crop protection agents |
| 05/27/2004 | US20040102512 Statins reduce or repress T-lymphocyte activation mediated by MHC class II or CD40; new target is alternative to cytokine inhibitors |
| 05/27/2004 | US20040102488 Antiinflamamtory agents; autoimmune diseases; antiarthritic agents; anticancer agents; Alzheimer's disease |
| 05/27/2004 | US20040102327 Pesticides, herbicides; spiropyran-pyrroline-2-one deriva-tives |
| 05/27/2004 | US20040101544 Method for detoxifying a carbohydrate containing solution |
| 05/27/2004 | CA2504737A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/26/2004 | EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
| 05/26/2004 | EP1421056A1 (alpha)-haloenamine reagents |
| 05/25/2004 | CA2267059C Sordarin derivatives |
| 05/25/2004 | CA2081935C Anilide derivatives and their use for combating botrytis |
| 05/25/2004 | CA2048172C Substituted sulfonamids, preparation processes and drugs containing same |
| 05/21/2004 | WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/20/2004 | US20040097594 Sulfonamide inhibitors of aspartyl protease |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097402 Therapy for infections; bactericides; synergistic mixtures |
| 05/18/2004 | US6737541 Preparation of nitrogen mustard derivatives |
| 05/14/2004 | WO2004043944A1 Pharmacologically active novel dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same |
| 05/14/2004 | CA2462181A1 Pharmacologically active novel dauer pheromone compound for controlling aging and stress and method for isolating and characterizing the same |
| 05/13/2004 | US20040092770 Alpha-haloenamine reagents |
| 05/13/2004 | US20040092754 Boronation, formylation, carbonylation, carboxylation, esterification, silanation, sulfiding, bromination, iodination, and/or chlorination |
| 05/13/2004 | US20040092753 Method for producing unsaturated cyclic ethers |
| 05/13/2004 | US20040092742 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 05/13/2004 | US20040092581 Ratjadone derivatives for inhibiting cell growth |
| 05/12/2004 | EP1417196A1 Dna-pk inhibitors |
| 05/12/2004 | EP1417195A1 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 05/12/2004 | EP1149086B1 Novel process for the removal of a silyloxy protecting group from 4-silyloxy-tetrahydro-pyran-2-ones |
| 05/12/2004 | EP1026143B1 Novel liquid-crystal compounds having large negative value of permittivity anisotropy, liquid-crystal composition, and liquid-crystal display element |
| 05/12/2004 | EP1015441B1 Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors |
| 05/12/2004 | EP0910415B1 Fluoro-labelled anthracycline and anthracyclinone derivatives |
| 05/12/2004 | CN1496281A Improved method for producing unsaturated cyclic ethers |
| 05/12/2004 | CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy |
| 05/12/2004 | CN1149082C Di-and trivalent small molecule selecting protein inhibitors |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004037773A1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 05/06/2004 | WO2004037760A2 Process for producing optically active 2-alkoxy-1-(trifluoromethyl-substituted phenyl)ethanol derivatives |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087632 Controlling metabolism of lipids, cholesterol |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | EP1415984A1 Aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 05/06/2004 | EP1414810A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 05/06/2004 | EP1414463A1 Asymmetric synthesis of kavalactones |
| 05/06/2004 | EP1414434A1 Compounds which mimic the chemical and biological properties of discodermolide |
| 05/06/2004 | EP1241164B1 Process for preparation of tetrahydropyranyloxyamines |
| 05/06/2004 | EP0968182B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/06/2004 | EP0915825B1 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 05/06/2004 | CA2503588A1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 05/05/2004 | CN1494524A Process for stereo selective synthesis of prostacyclin derivatives |
| 05/05/2004 | CN1494425A Carboxamide derivatives as therapeutic agents |
| 05/05/2004 | CN1493570A Process for preparing |
| 05/05/2004 | CN1148346C Hydrazine derivs. |
| 04/29/2004 | WO2004036315A1 Photoresist base material, method for purification thereof, and photoresist compositions |
| 04/29/2004 | WO2004034999A2 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| 04/29/2004 | WO2003068825A3 Multifunctional monomers and their use in making cross-linked polymers and porous films |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | US20040082795 Asymmetric catalytic hydrogenation process for preparation of chiral cyclic beta-aminoesters |
| 04/29/2004 | US20040082651 Epothilone synthesis building blocks III and IV: asymmetrically substituted acyloins and acyloin derivatives, methods for their production and methods for the production of epothilones B, D and epothilone derivatives |
| 04/29/2004 | US20040081664 Oral delivery of a botanical |
| 04/29/2004 | CA2502227A1 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| 04/28/2004 | EP1413580A1 Furanone derivatives as inhibitors of Cathepsin S |
| 04/28/2004 | EP1412515A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 04/28/2004 | EP1247807B1 Processes for producing tetrahydropyranyl-4-sulfonate and 4-aminotetrahydropyran compound |
| 04/28/2004 | EP1154983B1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 04/22/2004 | WO2004002979A3 Chiral 3,4-dihydro-2h-pyran compounds |
| 04/22/2004 | WO2003007878A3 Antifungal agents of sordarin derivatives |
| 04/22/2004 | US20040077884 Lactonization of ammonium 7-(1,2,6,7,8,8a(R)-hexahydro-2(S), 6(R)-dimethyl-8(S)-(2,2-dimethylbutyryloxy)-1(S)-naphthyl)-3(R),5(R) -dihydroxyheptanoate |
| 04/21/2004 | EP1409468A2 Guanidinobenzamides as mc4-r agonists |
| 04/21/2004 | EP1235821B1 Pyrone derivatives and a method for producing same |
| 04/21/2004 | CN1490316A Compound for inducing plant male sterility |
| 04/21/2004 | CN1146536C Cycloethylene derivatives |
| 04/21/2004 | CN1146534C (4S,5S)-and(4R, 5R)-gamma-methyl-delta-hydroxyl-alkanoic acid and its alkyl ester, preparation method and application |
| 04/21/2004 | CN1146472C Catalyst for catalyzing unsymmetrical hetero-Diels-Alder reaction, its preparation and application |
| 04/15/2004 | WO2004031149A1 Substituted gamma-phenyl-delta-lactams and uses related thereto |
| 04/15/2004 | WO2004030684A2 Kavalactone product |
| 04/15/2004 | WO2003083063A3 Common ligand mimics: naphtoates |
| 04/15/2004 | US20040073049 Process for preparing intermediates for the manufacture of discodermolide and discodermolide analogues |
| 04/15/2004 | US20040072897 Solvent extraction from plant using liquid carbon dioxide; therapy for muscular disorders |
| 04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
| 04/15/2004 | US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders |
| 04/15/2004 | US20040072802 Antiarthritic agents; antiulcer agents; bone disorders; antitumor agents; oral diseases |
| 04/15/2004 | US20040072767 Glucopyranose derivatives and medicaments for preventing and/or treating HIV infection diseases comprising the same as an active ingredient |
| 04/15/2004 | US20040071794 Administering methysticin, dihydromethysticin, desmethoxyyangonin, yangonin, dihydrokavain, and/or kavain as drug intensifier |
| 04/14/2004 | EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors |
| 04/14/2004 | EP1100772B1 Open chain alkoxyamine compounds and their use as polymerization regulators |
| 04/13/2004 | US6720463 Process for the production of alkanediol derivative |
| 04/13/2004 | US6720425 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 04/13/2004 | US6720327 Lactone integrin antagonists |
| 04/13/2004 | US6720321 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/08/2004 | WO2004029033A1 Valerolactone compounds and perfume composition |
| 04/08/2004 | WO2003105769A3 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 04/08/2004 | WO2003018553A8 Oral antidiabetic agents |
| 04/08/2004 | US20040068123 Introduction of t-butyldimethylsilyl(TBDMS) group as an alcohol protection group and construction of deprotection reaction condition not to produce by-products promise highly pure production of simvastatin |
| 04/08/2004 | US20040065866 Low viscosity; solubility at low temperature; low voltage display device |
| 04/07/2004 | EP1404313A2 METHYL ANALOGS OF SIMVASTATIN AS NOVEL HMG-CoA REDUCTASE INHIBITORS |